Menu
Not yet recruiting NCT07288762

Gonadal Function in Thalassemic Patient

— Observational Thalassemia Majors (Beta-Thalassemia Major)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: serum inhibin B serum INSL3 serum AMH.
Who it may be relevant to
Registry conditions: Thalassemia Majors (Beta-Thalassemia Major). Basic parameters: 10 years — 18 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Gonadal Function in Boys With Transfusion Depandant Beta Thalassemia

Overview

Patient with transfusion depandant beta thalassemia with accumulation of iron in their body affect pituitary gland and gonades lead to impaired their functions .

Detailed description

detection of any abnormalities in pituitary gland hormones ( FSH , LH , serum prolactin ) gonadal hormones ( serum testesterone , antimullerian hormone , INSL3 , inhibin B hormone )

Interventions

  • Diagnostic test serum inhibin B serum INSL3 serum AMH
    transfusion depandant beta thalassemia with measure gonadal function serum INSL3 serum inhibin B serum AMH

Primary outcome measures

  • gonadal function in transfusion depandant beta thalassemia [Time frame: through study completion, an average of 1 year]

Eligibility criteria

Inclusion criteria

  • transfusion depandant beta thalassemia
  • age 10 to 18 year old age

Exclusion criteria

  • age below 10 year old age or above 18 year old age
  • associated with another disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-control

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07288762 · Soh-Med-25-9-18MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗